This retrospective, interventional case series analyses treatment outcomes in eyes with choroidal neovascularization (CNV) secondary to pathological myopia, managed with photodynamic therapy, (PDT), (Group __number__ , N = __number__ ), PDT and intravitreal triamcinolone acetonide ( __number__ mg/  __number__  ml) (Group __number__ , N = __number__ ), PDT and intravitreal anti-vascular endothelial growth factor (anti-VEGF) bevacizumab  __number__  mg/  __number__  ml, ranibizumab  __number__  mg/  __number__  ml and reduced-fluence PDT and intravitreal ranibizumab  __number__  mg/  __number__  ml (Group __number__ , N= __number__ ).